SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening.

Authors:
Wu J; Chen Z; Han X; Chen Q; Wang Y and 1 more

Journal:
Future Virol

Publication Year: 2022

DOI:
10.2217/fvl-2021-0335

PMCID:
PMC9910510

PMID:
36794167

Journal Information

Full Title: Future Virol

Abbreviation: Future Virol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Virology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Financial & competing interests disclosure: This work was financially supported by Suzhou Science and Technology Development Project (no. SNG2020058), the Jiangsu Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University (no. 202010285133Y), the 23rd Undergraduates Extracurricular Academic Research Fund, Soochow University (no. KY20210120A) and Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.: No writing assistance was utilized in the production of this manuscript."

Evidence found in paper:

"Financial & competing interests disclosure: This work was financially supported by Suzhou Science and Technology Development Project (no. SNG2020058), the Jiangsu Undergraduate Training Program for Innovation and Entrepreneurship, Soochow University (no. 202010285133Y), the 23rd Undergraduates Extracurricular Academic Research Fund, Soochow University (no. KY20210120A) and Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.: No writing assistance was utilized in the production of this manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025